Source link : https://newshealth.biz/health-news/brepocitinib-shows-positive-results-in-dermatomyositis-trial/
Once-daily oral brepocitinib 30 mg shows improvement in measures of skin and muscle disease in patients with dermatomyositis, compared with placebo, according to findings from a phase 3 study. Medscape Medical News Source link : https://www.medscape.com/viewarticle/brepocitinib-shows-positive-results-phase-3-dermatomyositis-2025a1000p1n?src=rss Author : Publish date : 2025-09-19 18:53:00 Copyright for syndicated content belongs to the linked Source.
The post Brepocitinib Shows Positive Results in Dermatomyositis Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-19 18:53:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8